RecruitingNCT06741540
Brain stimulation and supportive therapy during breast cancer chemotherapy for people with depression
About this title
Read the official source — NCT06741540Interventional studyAges 18–65China
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- HangzhouSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other
- Locations
- China
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06741540
- Official title
Show the full official title
Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Hangzhou
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Second Affiliated Hospital, Zhejiang University, School of Medicine, a university.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
